DL-Menthol

Overview

DL-Menthol (Racementhol) is an orally active, GABA a R positive allosteric modulator and UDP-glucuronosyltransferase ( UGT ) inhibitor that can cross the blood-brain barrier. DL-Menthol binds to GABA A R and exhibits an allosteric activation effect, enhancing GABA-mediated chloride influx and inhibiting neuronal excitability. DL-Menthol can induce surgical anesthesia in fish and inhibit the metabolic detoxification of tobacco carcinogens by human liver and intestinal UGT enzymes, resulting in reduced NNAL-N-Gluc production.

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Depression | Products > Disease Areas > SARS-CoV-2 Infection | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Coronavirus Infection | Products > Signaling Pathways > Others | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Research Areas > Infection | Products > Signaling Pathways > Environmental Pollutants | Products > Signaling Pathways > GABA Receptor

Product Information

• Catalog No.: HY-Y1683
• CAS No.: 89-78-1
• Molecular Formula: C10H20O
• Molecular Weight: 156.27
• Purity: 98.0%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (16.00 mM); Clear solution
• Availability: In-stock

Source

Original product source